These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3399005)

  • 41. Effects of prostaglandin E1 on perihematomal tissue after hypertensive intracerebral hemorrhage.
    Cao M; Ke K; Sun H; Robertson A
    Acta Neurol Taiwan; 2011 Sep; 20(3):172-81. PubMed ID: 22009121
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prostaglandin E1 -containing nanoparticles improve walking activity in an experimental rat model of intermittent claudication.
    Ishihara T; Yamashita Y; Takasaki N; Yamamoto S; Hayashi E; Tahara K; Takenaga M; Yamakawa N; Ishihara T; Kasahara T; Mizushima T
    J Pharm Pharmacol; 2013 Aug; 65(8):1187-94. PubMed ID: 23837586
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of Long-term Administration of Prostaglandin E
    Iwaki R; Matsuhisa H; Minamisawa S; Akaike T; Hoshino M; Yagi N; Morita K; Shinohara G; Kaneko Y; Yoshitake S; Takahashi M; Tsukube T; Oshima Y
    Ann Thorac Surg; 2020 Dec; 110(6):2088-2095. PubMed ID: 32246933
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Carbon dioxide reactivity and local cerebral blood flow during prostaglandin E1- or nitroglycerin-induced hypotension.
    Abe K; Iwanaga H; Yoshiya I
    Can J Anaesth; 1992 Oct; 39(8):799-804. PubMed ID: 1288905
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rate of release and retentivity of prostaglandin E1 in lipid emulsion.
    Yamaguchi T; Fukushima Y; Itai S; Hayashi H
    Biochim Biophys Acta; 1995 Jun; 1256(3):381-6. PubMed ID: 7786903
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CXC chemokine receptor 4 is essential for Lipo-PGE1-enhanced migration of human dermal fibroblasts.
    Yang Y; Shim SK; Kim HA; Seon M; Yang E; Cho D; Bang SI
    Exp Dermatol; 2012 Jan; 21(1):75-7. PubMed ID: 22151395
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transcranial Doppler pattern after intracarotid papaverine and prostaglandin E1 incorporated in lipid microsphere in patients with vasospasm.
    Kanamaru K; Waga S; Kuga Y; Nakamura F; Kamata N
    Neurol Med Chir (Tokyo); 1998; 38 Suppl():152-5. PubMed ID: 10234998
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effects of lipo-prostaglandin E1 on axial pattern flaps in rabbits.
    Kuwahara H; Fazhi Q; Sugihara T; Ohura T; Igawa H; Yamamoto Y
    Ann Plast Surg; 1995 Dec; 35(6):620-6. PubMed ID: 8748345
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of prostaglandin E1 on cerebral blood flow in patients with chronic cerebral infarction.
    Komaba Y; Kitamura S; Terashi A
    Intern Med; 1998 Oct; 37(10):841-6. PubMed ID: 9840705
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Neurological Safety of an Epidurally Administered Lipo-PGE1 Agonist in Rats.
    Choi E; Im SM; Yoo HS; Nahm FS; Kim YH; Choe G; Lee PB
    Reg Anesth Pain Med; 2017; 42(1):75-81. PubMed ID: 27922949
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Effect of prostaglandin E1 treatment on peripheral circulation during extracorporeal circulation--with special reference to its influence on body temperature recovery].
    Tabata R; Mori A; Watarida S; Onoe M; Shiraishi S; Nojima T; Matsuno S
    Nihon Kyobu Geka Gakkai Zasshi; 1992 Jan; 40(1):6-12. PubMed ID: 1564355
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of age in determining the effects of lipo-PGE1 infusion on immediate arterial maximal flow velocity in patients with diabetes undergoing free flap surgery for lower extremity reconstruction: A prospective observational study.
    Park JY; Jin SJ; Suh HP; Lee SA; Cho C; Yu J; Hwang JH; Hong JP; Kim YK
    J Plast Reconstr Aesthet Surg; 2020 May; 73(5):885-892. PubMed ID: 31924534
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of complications of peripheral obstructive arterial disease with prostaglandin E1.
    Killion DD; Ambrus JL
    Angiology; 1987 Jul; 38(7):507-13. PubMed ID: 3619123
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [A random sample study of therapeutic effect of beta-receptor blocking agents in patients with subarachnoid hemorrhage].
    Wang ML
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Jun; 24(3):141-3, 187. PubMed ID: 1889320
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vasodilating effect and tissue accumulation of prostaglandin E1 incorporated in lipid microspheres on the rat ductus arteriosus.
    Chino Y; Minagawa T; Kohno Y; Fukushima K; Momma K
    Jpn J Pharmacol; 1999 Sep; 81(1):107-14. PubMed ID: 10580378
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Application of lipid microspheres containing prostaglandin E1 ointment to peripheral ischemic ulcers.
    Sakakibara Y; Jikuya T; Mitsui T
    Dermatology; 1997; 195(3):253-7. PubMed ID: 9407173
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of hypervolemic therapy on cerebral blood flow after subarachnoid hemorrhage : a randomized controlled trial.
    Lennihan L; Mayer SA; Fink ME; Beckford A; Paik MC; Zhang H; Wu YC; Klebanoff LM; Raps EC; Solomon RA
    Stroke; 2000 Feb; 31(2):383-91. PubMed ID: 10657410
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hemodynamic effects of lipo-PGE1 on peripheral artery in patients with diabetic neuropathy: evaluated by two-dimensional color Doppler echography.
    Okuda Y; Mizutani M; Ogawa M; Sone H; Asano M; Tsurushima Y; Morishima Y; Asakura Y; Suzuki S; Isaka M
    Diabetes Res; 1993; 22(2):87-95. PubMed ID: 8205741
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Echocardiographic evaluation of the ductal morphology in patients with refractoriness to lipo-prostaglandin E1 therapy.
    Takeda N; Hiraishi S; Misawa H; Agata Y; Horiguchi Y; Fujino N; Hirota H; Kawamura S; Ogawa N
    Pediatr Int; 2000 Apr; 42(2):134-8. PubMed ID: 10804727
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Specific augmentation of plantar skin blood flow by lipo-PGE1 assessed in tetrodotoxin- and N(G)-nitro-L-arginine-treated rats.
    Chino D; Akimaru S; Kataha K; Ishii K; Nakayama K
    J Cardiovasc Pharmacol; 2000 Apr; 35(4):630-7. PubMed ID: 10774795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.